Sound Shore Management, an investment management firm, has released its investor letter for the fourth quarter of 2024. A ...
U.S. President Donald Trump's administration needs to speed up generic drug approvals and exempt some drugs from funding ...
Bank Leumi (TASE: LUMI) led the market today, falling 1.02% on the day's biggest trading turnover. Bank Hapoalim (TASE: POLI) fell 1.37%, Mizrahi Tefahot Bank fell 0.53% and Israel Discount Bank (TASE ...
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has opened the reporting season for Israeli companies by publishing its fourth quarter and full-year 2024 financial results. In the ...
1 Day TEVA -0.75% DJIA 0.16% S&P 500 0.24% Health Care/Life Sciences -0.28% ...
SaverOne 2014 Ltd. Teva, a global pharmaceutical leader, to install the SaverOne System across its entire fleet of 50 delivery trucks in Israel Petah Tikvah, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE ...
Parents and activists say that the state is delaying switching Bedouin schools from dangerous generators to solar panels ...
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel ...
U.S. President Donald Trump's administration needs to speed up generic drug approvals and exempt some drugs from funding ...
Hosted on MSN26d
Teva falls sharply on disappointing 2025 guidanceOverall 2024 was a successful year for Teva. The share price rose 111% during the year, giving it a market cap of $25 billion, making it once again Israel's most valuable company. The share price ...
1 Day TEVA -5.67% DJIA -0.75% S&P 500 -0.50% Health Care/Life Sciences 0.29% ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results